3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
111
Triple Negative Breast Neoplasms
25
Lung Neoplasms
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Laryngeal Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Bile Duct Neoplasms
2
Interventions
Fulvestrant
4
ribociclib
3
palbociclib
3
abemaciclib
3
Anastrozole
3
selpercatinib
2
exemestane
2
Trastuzumab
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Docetaxel
2
AZD9833
2
tucatinib
1
ipatasertib
1
glutathione pegylated liposomal doxorubicin
1
entinostat
1
elacestrant
1
atezolizumab
1
alectinib
1
Zoledronic Acid
1
Watchful Waiting
1
Trabectedin
1
Tamoxifen
1
Sodium Chloride
1
STX-478
1
RAD1901
1
Paclitaxel
1
Metformin
1
Imlunestrant
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Drug Therapy
×
Breast
×
Clear all
NCT01204801
2015-09-24
Medifocus301
Medifocus, Inc.
Phase 3
Unknown
238 enrolled